83 related articles for article (PubMed ID: 32948788)
21. Disease modeling of desmosome-related cardiomyopathy using induced pluripotent stem cell-derived cardiomyocytes.
Higo S
World J Stem Cells; 2023 Mar; 15(3):71-82. PubMed ID: 37007457
[TBL] [Abstract][Full Text] [Related]
22. Human-Induced Pluripotent Stem Cell-Derived Cardiomyocyte Model for
Kondo T; Higo S; Shiba M; Kohama Y; Kameda S; Tabata T; Inoue H; Okuno S; Ogawa S; Nakamura S; Takeda M; Ito E; Li J; Liu L; Kuramoto Y; Lee JK; Takashima S; Miyagawa S; Sawa Y; Hikoso S; Sakata Y
Circ Genom Precis Med; 2022 Oct; 15(5):e003522. PubMed ID: 35861968
[TBL] [Abstract][Full Text] [Related]
23. CRISPR Modeling and Correction of Cardiovascular Disease.
Liu N; Olson EN
Circ Res; 2022 Jun; 130(12):1827-1850. PubMed ID: 35679361
[TBL] [Abstract][Full Text] [Related]
24. Fludarabine increases nuclease-free AAV- and CRISPR/Cas9-mediated homologous recombination in mice.
Tsuji S; Stephens CJ; Bortolussi G; Zhang F; Baj G; Jang H; de Alencastro G; Muro AF; Pekrun K; Kay MA
Nat Biotechnol; 2022 Aug; 40(8):1285-1294. PubMed ID: 35393561
[TBL] [Abstract][Full Text] [Related]
25. Efficient In Vivo Homology-Directed Repair Within Cardiomyocytes.
Zheng Y; VanDusen NJ; Butler CE; Ma Q; King JS; Pu WT
Circulation; 2022 Mar; 145(10):787-789. PubMed ID: 35254919
[No Abstract] [Full Text] [Related]
26. The use of new CRISPR tools in cardiovascular research and medicine.
Nishiga M; Liu C; Qi LS; Wu JC
Nat Rev Cardiol; 2022 Aug; 19(8):505-521. PubMed ID: 35145236
[TBL] [Abstract][Full Text] [Related]
27. The Role of Recombinant AAV in Precise Genome Editing.
Bijlani S; Pang KM; Sivanandam V; Singh A; Chatterjee S
Front Genome Ed; 2021; 3():799722. PubMed ID: 35098210
[TBL] [Abstract][Full Text] [Related]
28. Modeling reduced contractility and impaired desmosome assembly due to plakophilin-2 deficiency using isogenic iPS cell-derived cardiomyocytes.
Inoue H; Nakamura S; Higo S; Shiba M; Kohama Y; Kondo T; Kameda S; Tabata T; Okuno S; Ikeda Y; Li J; Liu L; Yamazaki S; Takeda M; Ito E; Takashima S; Miyagawa S; Sawa Y; Hikoso S; Sakata Y
Stem Cell Reports; 2022 Feb; 17(2):337-351. PubMed ID: 35063130
[TBL] [Abstract][Full Text] [Related]
29. Targeted Gene Delivery: Where to Land.
Pavani G; Amendola M
Front Genome Ed; 2020; 2():609650. PubMed ID: 34713234
[TBL] [Abstract][Full Text] [Related]
30. Bioengineering Technologies for Cardiac Regenerative Medicine.
Chingale M; Zhu D; Cheng K; Huang K
Front Bioeng Biotechnol; 2021; 9():681705. PubMed ID: 34150737
[TBL] [Abstract][Full Text] [Related]
31. Phenotypic recapitulation and correction of desmoglein-2-deficient cardiomyopathy using human-induced pluripotent stem cell-derived cardiomyocytes.
Shiba M; Higo S; Kondo T; Li J; Liu L; Ikeda Y; Kohama Y; Kameda S; Tabata T; Inoue H; Nakamura S; Takeda M; Ito E; Takashima S; Miyagawa S; Sawa Y; Hikoso S; Sakata Y
Hum Mol Genet; 2021 Jul; 30(15):1384-1397. PubMed ID: 33949662
[TBL] [Abstract][Full Text] [Related]
32. Homology-based repair induced by CRISPR-Cas nucleases in mammalian embryo genome editing.
Zhang X; Li T; Ou J; Huang J; Liang P
Protein Cell; 2022 May; 13(5):316-335. PubMed ID: 33945139
[TBL] [Abstract][Full Text] [Related]
33. DGK and DZHK position paper on genome editing: basic science applications and future perspective.
Brandes RP; Dueck A; Engelhardt S; Kaulich M; Kupatt C; De Angelis MT; Leisegang MS; le Noble F; Moretti A; Müller OJ; Skryabin BV; Thum T; Wurst W
Basic Res Cardiol; 2021 Jan; 116(1):2. PubMed ID: 33449167
[TBL] [Abstract][Full Text] [Related]
34. hiPSC-Derived Cardiac Tissue for Disease Modeling and Drug Discovery.
Li J; Hua Y; Miyagawa S; Zhang J; Li L; Liu L; Sawa Y
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33255277
[TBL] [Abstract][Full Text] [Related]
35. Adeno-associated virus-mediated gene delivery promotes S-phase entry-independent precise targeted integration in cardiomyocytes.
Kohama Y; Higo S; Masumura Y; Shiba M; Kondo T; Ishizu T; Higo T; Nakamura S; Kameda S; Tabata T; Inoue H; Motooka D; Okuzaki D; Takashima S; Miyagawa S; Sawa Y; Hikoso S; Sakata Y
Sci Rep; 2020 Sep; 10(1):15348. PubMed ID: 32948788
[TBL] [Abstract][Full Text] [Related]
36. Genome editing in human hematopoietic stem and progenitor cells via CRISPR-Cas9-mediated homology-independent targeted integration.
Bloomer H; Smith RH; Hakami W; Larochelle A
Mol Ther; 2021 Apr; 29(4):1611-1624. PubMed ID: 33309880
[TBL] [Abstract][Full Text] [Related]
37. Transplacental delivery of genome editing components causes mutations in embryonic cardiomyocytes of mid-gestational murine fetuses.
Nakamura S; Ishihara M; Ando N; Watanabe S; Sakurai T; Sato M
IUBMB Life; 2019 Jul; 71(7):835-844. PubMed ID: 30635953
[TBL] [Abstract][Full Text] [Related]
38. Targeted Genome Replacement via Homology-directed Repair in Non-dividing Cardiomyocytes.
Ishizu T; Higo S; Masumura Y; Kohama Y; Shiba M; Higo T; Shibamoto M; Nakagawa A; Morimoto S; Takashima S; Hikoso S; Sakata Y
Sci Rep; 2017 Aug; 7(1):9363. PubMed ID: 28839205
[TBL] [Abstract][Full Text] [Related]
39. Postnatal Cardiac Gene Editing Using CRISPR/Cas9 With AAV9-Mediated Delivery of Short Guide RNAs Results in Mosaic Gene Disruption.
Johansen AK; Molenaar B; Versteeg D; Leitoguinho AR; Demkes C; Spanjaard B; de Ruiter H; Akbari Moqadam F; Kooijman L; Zentilin L; Giacca M; van Rooij E
Circ Res; 2017 Oct; 121(10):1168-1181. PubMed ID: 28851809
[TBL] [Abstract][Full Text] [Related]
40. Purification of Pluripotent Stem Cell-Derived Cardiomyocytes Using CRISPR/Cas9-Mediated Integration of Fluorescent Reporters.
Galdos FX; Darsha AK; Paige SL; Wu SM
Methods Mol Biol; 2021; 2158():223-240. PubMed ID: 32857377
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
